RNS Number : 2577N
Synergia Energy Ltd
07 May 2024
 

A picture containing icon Description automatically generated

RNS Announcement

 

7 May 2024

 

AIM: SYN

Update on Government of India Approval for Working Interest Transfer

 

Further to its announcement on 14 February 2024, Synergia Energy Limited ("Synergia" or the "Company") provides the following update regarding the pending approval by the Government of India ("GOI") for the transfer of a 50% interest in the Company's Cambay Field Production Sharing Contract ("Cambay PSC") to Selan Exploration Technology Limited ("Selan").

Extensive dialogue between Synergia and the two GOI regulators, the Directorate General of Hydrocarbons ("DGH") and the Ministry of Petroleum and Natural Gas ("MOPNG"), has been underway since early March 2024 to expedite the transfer of the 50% interest in the Cambay PSC to Selan.

At this time, Synergia believes all the necessary formalities have now been processed for the GOI approval to be issued once Ministerial sign-off has occurred.

 

For and on behalf of Synergia Energy Limited

 

 

 

 

 

 

Roland Wessel

CEO

For further information, please contact:

 

Investor Enquires

Synergia Energy Ltd

Briana Stayt

Investor Relations

Email: 

bstayt@synergiaenergy.com

Tel: +61 8 9485 3200

Australia

AIM Joint Broker

Panmure Gordon (UK) Ltd

Broker

Mark Murphy / Hugh Rich / Freddie Wooding

Tel: +44 (0)20 7886 2500

UK

AIM Joint Broker

Novum Securities

Broker

Colin Rowbury

Email: 

crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Ritchie Balmer / Rory Murphy

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Consulting

Investor Relations

Patrick d'Ancona / Finlay Thomson

Email:

patrick.dancona@vigoconsulting.com

finlay.thomson@vigoconsulting.com

Tel:+ 44 20 7390 0230

UK

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUWGAUPCGQW